TapewireFind a company

person · Reporting owner

SRINIVASAN RAMESH

Disclosed activity across 1 company

Tapewire entity
25668
SEC CIK
0001277036

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
AGILYSYS INCAGYS · Entity 897Director · President & CEOAugust 05, 2026August 07, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AGILYSYS INC

Report date August 05, 2026 · Filed August 07, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect610,044 Ending reported balance After 2026-08-07 transaction · row 4
4 source rows · reconciled sequence

Row 1 · 2026-08-05 · Sale · Disposed 66,205 · Balance 741,249

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.92 to $110.62. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Row 2 · 2026-08-06 · Sale · Disposed 66,205 · Balance 675,044

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.32 to $108.32. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Row 3 · 2026-08-06 · Sale · Disposed 40,000 · Balance 635,044

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.48 to $108.09. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Row 4 · 2026-08-07 · Sale · Disposed 25,000 · Balance 610,044

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.20 to $109.80. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Common StockSEC Table I · non-derivativeIndirectBy Ramesh and Sujatha Srinivasan Living Trust60,000 Reported balance Holding disclosure · report date 2026-08-05 · row 5 Holding and transaction disclosures are not merged.
1 source row

Row 5 · Balance 60,000

Filing footnotes · ownership attribution and instrument terms

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.92 to $110.62. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.32 to $108.32. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.48 to $108.09. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.20 to $109.80. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 04, 2019 Filed Sep 4, 2019 20:57 UTC AGILYSYS INC AGYS · Entity 897 PurchaseCommon Stock 10,000 $25.13 $251,300.00
Disclosure

SEC source: 0001209191-19-048242 · doc4.xml · nonDerivative · entry 1

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,348

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.01 to $25.20, inclusive. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

Read SEC document
July 31, 2019 Filed Aug 2, 2019 15:20 UTC AGILYSYS INC AGYS · Entity 897 PurchaseCommon Stock 11,000 $24.59 $270,490.00
Disclosure

SEC source: 0001209191-19-044153 · doc4.xml · nonDerivative · entry 1

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,348

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.36 to $24.74, inclusive. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

Read SEC document
June 20, 2019 Filed Jun 24, 2019 20:50 UTC AGILYSYS INC AGYS · Entity 897 GrantPerformance Rights · Derivative 30,120 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-038795 · doc4.xml · derivative · entry 1

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,120

Underlying: Common Stock · 30,120 shares

Expires 2020-06-20

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of AGYS common stock. The performance rights vest upon certain performance goals being met for the fiscal year ending March 31, 2020. Upon a "Change in Control" (as defined in the 2016 Stock Incentive Plan), up to a maximum stock value of $675,000 would automatically be deemed earned, regardless of achievement of the performance goal, and would automatically vest.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of AGYS common stock. The performance rights vest upon certain performance goals being met for the fiscal year ending March 31, 2020. Upon a "Change in Control" (as defined in the 2016 Stock Incentive Plan), up to a maximum stock value of $675,000 would automatically be deemed earned, regardless of achievement of the performance goal, and would automatically vest.

Read SEC document
May 31, 2019 Filed Jun 4, 2019 20:31 UTC AGILYSYS INC AGYS · Entity 897 Exercise / conversionPerformance Rights · Derivative 63,291 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-034286 · doc4.xml · derivative · entry 3

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 63,291 shares

Expires 2019-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Conversion of performance rights for common stock upon the attainment of certain perfomance goals for the fiscal year ending March 31, 2019, which common stock vested on May 31, 2019. All unearned performance rights expired on May 31, 2019.

F1 · price: Conversion of performance rights for common stock upon the attainment of certain perfomance goals for the fiscal year ending March 31, 2019, which common stock vested on May 31, 2019. All unearned performance rights expired on May 31, 2019.

F1 · derivative.exercise_date: Conversion of performance rights for common stock upon the attainment of certain perfomance goals for the fiscal year ending March 31, 2019, which common stock vested on May 31, 2019. All unearned performance rights expired on May 31, 2019.

Read SEC document
May 31, 2019 Filed Jun 4, 2019 20:31 UTC AGILYSYS INC AGYS · Entity 897 Exercise / conversionCommon Stock 23,526 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-034286 · doc4.xml · nonDerivative · entry 1

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,348

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Conversion of performance rights for common stock upon the attainment of certain perfomance goals for the fiscal year ending March 31, 2019, which common stock vested on May 31, 2019. All unearned performance rights expired on May 31, 2019.

F1 · price: Conversion of performance rights for common stock upon the attainment of certain perfomance goals for the fiscal year ending March 31, 2019, which common stock vested on May 31, 2019. All unearned performance rights expired on May 31, 2019.

Read SEC document
February 06, 2019 Filed Feb 6, 2019 21:48 UTC AGILYSYS INC AGYS · Entity 897 PurchaseCommon Stock 2,221 $18.71 $41,554.91
Disclosure

SEC source: 0001209191-19-007769 · doc4.xml · nonDerivative · entry 2

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,822

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.59 to $18.90, inclusive.

Read SEC document
February 05, 2019 Filed Feb 6, 2019 21:48 UTC AGILYSYS INC AGYS · Entity 897 PurchaseCommon Stock 17,779 $18.36 $326,422.44
Disclosure

SEC source: 0001209191-19-007769 · doc4.xml · nonDerivative · entry 1

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,601

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.01 to $18.55, inclusive. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes (1) and (2) to this Form 4.

Read SEC document
August 07, 2018 Filed Aug 8, 2018 12:40 UTC AGILYSYS INC AGYS · Entity 897 PurchaseCommon Stock 6,360 $15.32 $97,435.20
Disclosure

SEC source: 0001209191-18-045773 · doc4.xml · nonDerivative · entry 2

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,822

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.20 to $15.50, inclusive.

Read SEC document
August 06, 2018 Filed Aug 8, 2018 12:40 UTC AGILYSYS INC AGYS · Entity 897 PurchaseCommon Stock 28,640 $15.40 $441,056.00
Disclosure

SEC source: 0001209191-18-045773 · doc4.xml · nonDerivative · entry 1

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,462

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.20 to $15.53, inclusive. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes (1) and (2) to this Form 4.

Read SEC document
June 14, 2018 Filed Jun 18, 2018 22:32 UTC AGILYSYS INC AGYS · Entity 897 Exercise / conversionPerformance Rights · Derivative 91,463 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-038419 · doc4.xml · derivative · entry 3

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 91,463 shares

Expires 2018-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Conversion of performance rights for common stock upon the attainment of certain perfomance goals for the fiscal year ending March 31, 2018, which common stock vested on June 14, 2018. All unearned performance rights expired on June 14, 2018.

F1 · price: Conversion of performance rights for common stock upon the attainment of certain perfomance goals for the fiscal year ending March 31, 2018, which common stock vested on June 14, 2018. All unearned performance rights expired on June 14, 2018.

F1 · derivative.exercise_date: Conversion of performance rights for common stock upon the attainment of certain perfomance goals for the fiscal year ending March 31, 2018, which common stock vested on June 14, 2018. All unearned performance rights expired on June 14, 2018.

Read SEC document
June 14, 2018 Filed Jun 18, 2018 22:32 UTC AGILYSYS INC AGYS · Entity 897 Exercise / conversionCommon Stock 15,822 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-038419 · doc4.xml · nonDerivative · entry 1

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,822

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Conversion of performance rights for common stock upon the attainment of certain perfomance goals for the fiscal year ending March 31, 2018, which common stock vested on June 14, 2018. All unearned performance rights expired on June 14, 2018.

F1 · price: Conversion of performance rights for common stock upon the attainment of certain perfomance goals for the fiscal year ending March 31, 2018, which common stock vested on June 14, 2018. All unearned performance rights expired on June 14, 2018.

Read SEC document
May 31, 2018 Filed Jun 5, 2018 01:11 UTC AGILYSYS INC AGYS · Entity 897 GrantPerformance Rights · Derivative 63,291 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-035419 · doc4.xml · derivative · entry 1

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,291

Underlying: Common Stock · 63,291 shares

Expires 2019-05-31

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of AGYS common stock. The performance rights vest upon certain performance goals being met for the fiscal year ending March 31, 2019. Upon a "Change in Control" (as defined in the 2016 Stock Incentive Plan), up to a maximum stock value of $900,000 would automatically be deemed earned, regardless of achievement of the performance goal, and would automatically vest.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of AGYS common stock. The performance rights vest upon certain performance goals being met for the fiscal year ending March 31, 2019. Upon a "Change in Control" (as defined in the 2016 Stock Incentive Plan), up to a maximum stock value of $900,000 would automatically be deemed earned, regardless of achievement of the performance goal, and would automatically vest.

Read SEC document
November 10, 2017 Filed Nov 13, 2017 17:02 UTC AGILYSYS INC AGYS · Entity 897 PurchaseCommon Stock 15,000 $11.93 $178,950.00
Disclosure

SEC source: 0000950138-17-000744 · edgar.xml · nonDerivative · entry 2

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.62 to $12.00, inclusive.

Read SEC document
November 09, 2017 Filed Nov 13, 2017 17:02 UTC AGILYSYS INC AGYS · Entity 897 PurchaseCommon Stock 35,000 $11.70 $409,500.00
Disclosure

SEC source: 0000950138-17-000744 · edgar.xml · nonDerivative · entry 1

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.37 to $11.805, inclusive. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes (1) and (2) to this Form 4.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 22:55 UTC AGILYSYS INC AGYS · Entity 897 GrantPerformance Rights · Derivative 91,463 $0.00 $0.00
Disclosure

SEC source: 0000950138-17-000501 · edgar.xml · derivative · entry 1

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,463

Underlying: Common Stock · 91,463 shares

Expires 2018-03-31

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of AGYS common stock. The performance rights vest upon certain performance goals being met for the fiscal year ending March 31, 2018. Upon a "Change in Control" (as defined in the 2016 Stock Incentive Plan), up to a maximum stock value of $900,000 would automatically be deemed earned, regardless of achievement of the performance goal, and would automatically vest.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of AGYS common stock. The performance rights vest upon certain performance goals being met for the fiscal year ending March 31, 2018. Upon a "Change in Control" (as defined in the 2016 Stock Incentive Plan), up to a maximum stock value of $900,000 would automatically be deemed earned, regardless of achievement of the performance goal, and would automatically vest.

Read SEC document
February 15, 2017 Filed Feb 16, 2017 21:02 UTC AGILYSYS INC AGYS · Entity 897 PurchaseCommon Stock 50,424 $9.66 $487,095.84
Disclosure

SEC source: 0000950138-17-000180 · edgar.xml · nonDerivative · entry 2

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ramesh and Sujatha Srinivasan Living Trust

Disclosed balance after: 60,000

F2 · price: Weighted average price. Shares purchased at prices between $9.50 and $9.91.

Read SEC document
February 14, 2017 Filed Feb 16, 2017 21:02 UTC AGILYSYS INC AGYS · Entity 897 PurchaseCommon Stock 9,576 $9.41 $90,110.16
Disclosure

SEC source: 0000950138-17-000180 · edgar.xml · nonDerivative · entry 1

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ramesh and Sujatha Srinivasan Living Trust

Disclosed balance after: 9,576

F1 · price: Weighted average price. Shares purchased at prices between $9.19 and $9.48.

Read SEC document
January 03, 2017 Filed Jan 13, 2017 22:50 UTC AGILYSYS INC AGYS · Entity 897 GrantStock-settled Appreciation Rights · Derivative 630,000 $0.00 Strike: $10.80 $0.00
Disclosure

SEC source: 0000950138-17-000070 · edgar.xml · derivative · entry 1

SRINIVASAN RAMESH · CIK 0001277036 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 630,000

Underlying: Common Stock · 630,000 shares

Expires 2021-07-03

F1 · security: Stock-settled appreciation rights ("SSARs") granted under the Agilysys, Inc. 2016 Stock Incentive Plan. 210,000 of the 630,000 SSARs vest on January 3, 2018. The remaining 420,000 SSARs vest monthly in equal increments from February 1, 2018 through January 1, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.